Word

DUVROQ

Status

Registered

Status Code

700

Status Date

Tuesday, June 11, 2019

Serial Number

88174362

Registration Number

5774646

Registration Date

Tuesday, June 11, 2019

Mark Type

4000

Filing Date

Tuesday, October 30, 2018

Published for Opposition

Tuesday, March 26, 2019

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

The wording "DUVROQ" has no meaning in a foreign language.

Trademark Events

Jun 29, 2023

Teas Change Of Correspondence Received

Jun 29, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Jun 29, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jun 29, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Jun 29, 2023

Teas Change Of Owner Address Received

Oct 28, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Oct 28, 2022

Teas Change Of Correspondence Received

Oct 28, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Oct 28, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Oct 28, 2022

Teas Change Of Owner Address Received

Jun 11, 2019

Registered-Principal Register

Mar 26, 2019

Official Gazette Publication Confirmation E-Mailed

Mar 26, 2019

Published For Opposition

Mar 6, 2019

Notification Of Notice Of Publication E-Mailed

Feb 8, 2019

Approved For Pub - Principal Register

Feb 7, 2019

Teas/Email Correspondence Entered

Feb 7, 2019

Correspondence Received In Law Office

Feb 5, 2019

Assigned To Lie

Feb 1, 2019

Teas Response To Suspension Inquiry Received

Jan 30, 2019

Notification Of Letter Of Suspension E-Mailed

Jan 30, 2019

Letter Of Suspension E-Mailed

Jan 30, 2019

Suspension Letter Written

Jan 28, 2019

Assigned To Examiner

Nov 14, 2018

New Application Office Supplied Data Entered

Nov 2, 2018

New Application Entered